Antidepressants CA2 Flashcards
Physical illness and mental illness are not related. T/F?
False. More than half of those with mental illness also have a chronic physical illness.
Etiology and pathophysiology of depression.
Primary cause:
Monoamine hypothesis: reduced number of neurotransmitters in brain (e.g. norepinephrine (NE), serotonin (5-HT), dopamine (DA)).
Secondary causes:
Endocrine disorders: hypothyroidism, T2DM in women
Cardioavascular: CAD, CHF, MI
Clinical presentation for MDD (In. SAD. CAGES)
o At least 5 symptoms have been present during the same 2-week period
o One of the symptoms must be depressed mood or lost of interest
Interest: decreased interest
Sleep: insomnia
Appetite: decreased appetite
Depressed: depressed mood
Concentration: impaired concentration and decision making
Activity: psychomotor retardation or agitation
Guilt: feelings of guilt or worthlessness
Energy: decreased energy or fatigue
Suicidal thoughts or attempts
o Symptoms cause significant distress or impairment in social, occupational or other important areas of functioning.
o Symptoms are not caused by an underlying medical condition or substance.
Assessments for depression
Clinician-rated
- Hamilton Rating Scale for Depression (HAM-D): “gold standard”
- Remission = HAM-D score ≤ 7 (Therapy goal: symptom-free)
Self-rated:
- Screening tool: Patient Health Questionnaire (PHQ-2)
- Assessment tool: PHQ-9
Score above 5 to be considered depressed
Treatment principle
Combination of non-pharmacological and pharmacological treatment method
Non-pharmacological therapy for depression
- Sleep hygiene
- Psychotherapy
Pharmacological therapies (in general)
- Antidepressants ± adjunctive medicines
- First-line (antidepressant monotherapy): SSRI, SNRI, Mirtazapine or Bupropion
Types of TCAs
Amitriptyline, clomipramine, dothiepin, imipramine, nortriptyline
Types of SSRIs
Escitalopram, fluvoxamine, fluoxetine, paroxetine, sertraline, citalopram
Types of SNRIs
Venlafaxine, duloxetine
Type of SMS
Vortioxetine
Type of NaSSA
Mirtazapine
RIMA
Moclobemide
Others
Bupropion, trazodone, agomelatine
Other psychiatric indication in addition to depression
- OCD
- Clomipramine, fluoxetine, fluvoxamine, sertraline - Anxiety disorders
- Escitalopram, paroxetine - Panic disorder
- Citalopram, sertraline - Generalized Anxiety Disorder
- Venlafaxine, duloxetine - Social Anxiety Disorder
- Moclobemide - Off-label for insomnia
- Trazodone - Smoking cessation
- Bupropion
TCAs:
- Type of antidepressants
- MOA
- Side effects
- Notes
Types: Amitriptyline -> Nortriptyline Imipramine -> Desipramine Dothiepin Clomipramine
MOA:
Blocks reuptake of 5HT and NA
Side effects:
- GI and sexual dysfunction
- Anticholinergic, sedation, orthostatic hypotension, seizures, weight gain, arrhythmia.
- Fatal on overdoses
Notes:
- 2° amines (nortriptyline, desipramine) have lower anticholinergic, sedation and cardiotoxic side effects
Phases of treatment
- Acute Phase Treatment
- Adequate trial = adequate dose + duration
- Delayed onset due to down-regulation of pre-synaptic autoreceptors.
- Time course of treatment response
» Physical symptoms may improve in 1-2 weeks (e.g. sleep, appetite)
» Mood symptoms take longer time to improve (e.g. 4-6 weeks) - Continuation Phase
- Initiation + Acute Phase + Continuation = total at least 6-12 months